Table 2.
Treatment | [Ca2+]i nM, mean ± SEM | Number of cells (n) |
---|---|---|
Baseline | 64 ± 5 | 79 |
Thrombin 10 nM | 2,141 ± 277a | 79 |
Baseline | 124 ± 12 | 17 |
Hirudin + thrombin (10 nM each) | 165 ± 16 | 17 |
Baseline | 64 ± 5 | 16 |
Hirudin + thrombin (25 nM each) | 109 ± 5 | 16 |
Baseline/U73122 10 μM | 53 ± 5 | 16 |
U73122 + thrombin 10 nM | 53 ± 4 | 16 |
Baseline | 94 ± 66 | 29 |
Thrombin (10 nM) | 1,120 ± 652a | 29 |
Baseline/Y27632 10 μM | 50 ± 39 | 38 |
Y27632 + thrombin | 1,027 ± 550a | 38 |
Hirudin (antithrombin) was preincubated with thrombin for 1 h at room temperature at equimolar or 3-fold higher concentration. In U73122 studies, cells were preincubated with 10 μM U73122 for 20 min before thrombin addition.
Statistical significance between baseline, peak, and 1 min postpeak (not shown) mean values, performed by one-way repeated measures ANOVA and SNK method for multiple pair-wise comparison (P < 0.001).